Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.

Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton L, Cunningham JM, DeFazio A, Doherty JA, Edwards RP, Gayther SA, Gentry-Maharaj A, Goodman MT, Høgdall E, Jensen A, Johnatty SE, Kiemeney LA, Kjaer SK, Larson MC, Lurie G, Massuger L, Menon U, Modugno F, Moysich KB, Ness RB, Pike MC, Ramus SJ, Rossing MA, Rothstein J, Song H, Thompson PJ, van den Berg DJ, Vierkant RA, Wang-Gohrke S, Wentzensen N, Whittemore AS, Wilkens LR, Wu AH, Yang H, Pearce CL, Schildkraut JM, Pharoah P, Goode EL, Fridley BL; Ovarian Cancer Association Consortium and the Australian Cancer Study.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):780-90. doi: 10.1158/1055-9965.EPI-15-1039. Epub 2016 Mar 14.

2.

A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.

Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, Doherty JA, Schildkraut JM, Kjaer SK, Ness RB, Menon U, Berchuck A, Mukherjee B, Roman L, Pharoah PD, Chenevix-Trench G, Olson S, Hogdall E, Wu AH, Pike MC, Stram DO, Pearce CL; Ovarian Cancer Association Consortium.

Int J Cancer. 2016 Dec 15;139(12):2646-2654. doi: 10.1002/ijc.30274. Epub 2016 Sep 16.

3.

Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.

Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Sutphen R, McLaughlin J, Narod SA, Goode EL, Schildkraut JM, Fenstermacher D, Phelan CM, Sellers TA.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1131-45. doi: 10.1158/1055-9965.EPI-10-1224. Epub 2011 Mar 29.

4.

Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.

Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM; for Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME, Goodman MT, Moysich K, Hogdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Vierkant RA, Weber RP, Ziogas A, Anton-Culver H, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Brinton L, Wentzensen N, Lissowska J, Garcia-Closas M, Massuger LF, Kiemeney LA, Van Altena AM, Aben KK, Berchuck A, Doherty JA, Iversen E, McGuire V, Moorman PG, Pharoah P, Pike MC, Risch H, Sieh W, Stram DO, Terry KL, Whittemore A, Wu AH, Schildkraut JM, Kjaer SK; Ovarian Cancer Association Consortium.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):880-90. doi: 10.1158/1055-9965.EPI-12-1030-T. Epub 2013 Mar 5.

5.

The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.

Shafrir AL, Rice MS, Gupta M, Terry KL, Rosner BA, Tamimi RM, Hecht JL, Tworoger SS.

Gynecol Oncol. 2016 Dec;143(3):628-635. doi: 10.1016/j.ygyno.2016.09.024. Epub 2016 Oct 5.

6.

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Merritt MA, De Pari M, Vitonis AF, Titus LJ, Cramer DW, Terry KL.

Hum Reprod. 2013 May;28(5):1406-17. doi: 10.1093/humrep/des466. Epub 2013 Jan 12.

7.

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.

Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT.

Am J Obstet Gynecol. 2004 Sep;191(3):733-40.

PMID:
15467532
8.

Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.

Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):209-16.

9.

Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk.

Jung SY, Ho G, Rohan T, Strickler H, Bea J, Papp J, Sobel E, Zhang ZF, Crandall C.

Breast Cancer Res Treat. 2017 Jul;164(2):475-495. doi: 10.1007/s10549-017-4272-y. Epub 2017 May 6.

PMID:
28478612
10.

Anthropometry and the risk of epithelial ovarian cancer.

Greer JB, Modugno F, Ness RB, Allen GO.

Cancer. 2006 May 15;106(10):2247-57.

11.
12.

Hormone replacement therapy and risk of epithelial ovarian cancer.

Purdie DM, Bain CJ, Siskind V, Russell P, Hacker NF, Ward BG, Quinn MA, Green AC.

Br J Cancer. 1999 Oct;81(3):559-63.

13.

Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR.

Am J Epidemiol. 2002 Aug 15;156(4):363-73.

PMID:
12181107
14.

Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.

Jung SY, Rohan T, Strickler H, Bea J, Zhang ZF, Ho G, Crandall C.

PLoS One. 2017 Oct 12;12(10):e0186296. doi: 10.1371/journal.pone.0186296. eCollection 2017.

15.

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E, Persson IR.

J Natl Cancer Inst. 2002 Apr 3;94(7):497-504.

PMID:
11929950
16.

Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.

Rivadeneira F, van Meurs JB, Kant J, Zillikens MC, Stolk L, Beck TJ, Arp P, Schuit SC, Hofman A, Houwing-Duistermaat JJ, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG.

J Bone Miner Res. 2006 Sep;21(9):1443-56.

17.

Correlations between genetic variance and adiposity measures, and gene x gene interactions for obesity in postmenopausal Vietnamese women.

Binh TQ, Nakahori Y, Hien VT, Khan NC, Lam NT, Mai le B, Yamamoto S.

J Genet. 2011 Apr;90(1):1-9.

18.

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.

Lee E, Schumacher F, Lewinger JP, Neuhausen SL, Anton-Culver H, Horn-Ross PL, Henderson KD, Ziogas A, Van Den Berg D, Bernstein L, Ursin G.

Breast Cancer Res. 2011 Apr 1;13(2):R37. doi: 10.1186/bcr2859.

19.

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.

Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P.

J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405.

PMID:
17018786
20.

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, Fournier A, Hankinson SE, Henderson BE, Hoover RN, Isaacs C, Johansson M, Kolonel LN, Kraft P, Lee IM, McCarty CA, Overvad K, Panico S, Peeters PH, Riboli E, Sanchez MJ, Schumacher FR, Skeie G, Stram DO, Thun MJ, Trichopoulos D, Zhang S, Ziegler RG, Hunter DJ, Lindström S, Canzian F.

J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63. doi: 10.1093/jnci/djr265. Epub 2011 Jul 26.

Supplemental Content

Support Center